| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Short Bowel Syndrome | 39 | 2024 | 353 | 7.630 |
Why?
|
| Parenteral Nutrition | 49 | 2024 | 659 | 7.020 |
Why?
|
| Intestinal Diseases | 29 | 2023 | 503 | 5.860 |
Why?
|
| Growth Disorders | 24 | 2024 | 634 | 5.170 |
Why?
|
| Tanzania | 82 | 2024 | 1390 | 4.400 |
Why?
|
| Dietary Supplements | 55 | 2024 | 3410 | 4.230 |
Why?
|
| Zinc | 21 | 2024 | 672 | 3.850 |
Why?
|
| Enteral Nutrition | 36 | 2024 | 794 | 3.680 |
Why?
|
| Nutritional Status | 38 | 2024 | 1597 | 3.290 |
Why?
|
| Anemia, Iron-Deficiency | 18 | 2023 | 369 | 3.270 |
Why?
|
| Child Development | 30 | 2024 | 2302 | 3.180 |
Why?
|
| Vitamin B 12 Deficiency | 8 | 2020 | 118 | 2.930 |
Why?
|
| Wasting Syndrome | 6 | 2021 | 96 | 2.900 |
Why?
|
| Diarrhea | 29 | 2024 | 1316 | 2.840 |
Why?
|
| Micronutrients | 21 | 2022 | 381 | 2.730 |
Why?
|
| Infant | 192 | 2024 | 36170 | 2.690 |
Why?
|
| Vitamins | 19 | 2021 | 1634 | 2.650 |
Why?
|
| Vitamin B 12 | 11 | 2020 | 524 | 2.500 |
Why?
|
| Malnutrition | 17 | 2024 | 622 | 2.390 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 12 | 2024 | 390 | 2.220 |
Why?
|
| Breast Feeding | 21 | 2024 | 1356 | 2.210 |
Why?
|
| Infant, Low Birth Weight | 18 | 2024 | 869 | 2.180 |
Why?
|
| Intestine, Small | 17 | 2024 | 1207 | 2.040 |
Why?
|
| Thinness | 10 | 2023 | 481 | 1.940 |
Why?
|
| Infant Nutritional Physiological Phenomena | 12 | 2019 | 351 | 1.860 |
Why?
|
| Energy Intake | 20 | 2018 | 2133 | 1.790 |
Why?
|
| Rehydration Solutions | 10 | 2021 | 43 | 1.740 |
Why?
|
| Infectious Disease Transmission, Vertical | 15 | 2016 | 1351 | 1.690 |
Why?
|
| Infant, Newborn | 103 | 2024 | 26200 | 1.680 |
Why?
|
| HIV Infections | 61 | 2024 | 17348 | 1.640 |
Why?
|
| Growth | 9 | 2016 | 366 | 1.630 |
Why?
|
| Energy Metabolism | 12 | 2015 | 2877 | 1.600 |
Why?
|
| Enterocolitis, Necrotizing | 15 | 2015 | 326 | 1.600 |
Why?
|
| Nutritional Sciences | 5 | 2024 | 144 | 1.510 |
Why?
|
| Child, Preschool | 119 | 2024 | 42225 | 1.510 |
Why?
|
| Basal Metabolism | 5 | 2014 | 161 | 1.430 |
Why?
|
| Body Composition | 14 | 2023 | 2427 | 1.430 |
Why?
|
| Anthropometry | 13 | 2023 | 1338 | 1.430 |
Why?
|
| Body Height | 18 | 2023 | 1566 | 1.430 |
Why?
|
| Child | 140 | 2024 | 80154 | 1.420 |
Why?
|
| Fluid Therapy | 11 | 2021 | 578 | 1.420 |
Why?
|
| Lactation | 5 | 2024 | 397 | 1.400 |
Why?
|
| Premature Birth | 16 | 2024 | 1784 | 1.400 |
Why?
|
| Fish Oils | 7 | 2022 | 483 | 1.400 |
Why?
|
| Pregnancy Complications, Infectious | 24 | 2024 | 2150 | 1.340 |
Why?
|
| Pregnancy | 86 | 2024 | 29893 | 1.320 |
Why?
|
| Nutritional Requirements | 9 | 2017 | 274 | 1.290 |
Why?
|
| Liver Diseases | 9 | 2020 | 1301 | 1.280 |
Why?
|
| Flagellin | 5 | 2019 | 124 | 1.240 |
Why?
|
| Child Nutritional Physiological Phenomena | 13 | 2022 | 292 | 1.230 |
Why?
|
| Dehydration | 8 | 2024 | 216 | 1.190 |
Why?
|
| Patient Discharge | 6 | 2024 | 3441 | 1.170 |
Why?
|
| Periodicals as Topic | 5 | 2021 | 1463 | 1.140 |
Why?
|
| Immunoglobulin A | 5 | 2023 | 979 | 1.140 |
Why?
|
| Critical Illness | 13 | 2024 | 2724 | 1.100 |
Why?
|
| Aftercare | 3 | 2024 | 913 | 1.100 |
Why?
|
| Catheter-Related Infections | 7 | 2018 | 273 | 1.070 |
Why?
|
| Humans | 362 | 2024 | 761222 | 1.070 |
Why?
|
| Citrulline | 5 | 2014 | 107 | 1.020 |
Why?
|
| Anemia | 11 | 2023 | 1504 | 0.990 |
Why?
|
| Parenteral Nutrition, Home | 4 | 2018 | 39 | 0.980 |
Why?
|
| Calorimetry, Indirect | 10 | 2014 | 173 | 0.980 |
Why?
|
| Double-Blind Method | 34 | 2023 | 12341 | 0.950 |
Why?
|
| Body Weight | 18 | 2023 | 4618 | 0.950 |
Why?
|
| Female | 242 | 2024 | 392552 | 0.940 |
Why?
|
| Diarrhea, Infantile | 9 | 2024 | 100 | 0.930 |
Why?
|
| Fat Emulsions, Intravenous | 11 | 2022 | 314 | 0.930 |
Why?
|
| Gastrointestinal Diseases | 8 | 2018 | 1201 | 0.930 |
Why?
|
| Vitamin D Deficiency | 8 | 2022 | 1388 | 0.910 |
Why?
|
| Prospective Studies | 82 | 2024 | 54437 | 0.910 |
Why?
|
| Intensive Care Units, Pediatric | 11 | 2017 | 1017 | 0.890 |
Why?
|
| Intestinal Volvulus | 4 | 2023 | 82 | 0.890 |
Why?
|
| Digestive System Abnormalities | 1 | 2023 | 49 | 0.880 |
Why?
|
| Acidosis, Lactic | 2 | 2023 | 146 | 0.860 |
Why?
|
| Nutrition Therapy | 2 | 2022 | 102 | 0.830 |
Why?
|
| Intestines | 14 | 2017 | 1908 | 0.820 |
Why?
|
| Iron | 12 | 2023 | 1791 | 0.820 |
Why?
|
| Infant Mortality | 8 | 2024 | 752 | 0.820 |
Why?
|
| Nutrition Disorders | 3 | 2017 | 204 | 0.820 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2020 | 361 | 0.810 |
Why?
|
| Child Mortality | 6 | 2024 | 199 | 0.800 |
Why?
|
| Prenatal Exposure Delayed Effects | 12 | 2022 | 2517 | 0.800 |
Why?
|
| Cholecalciferol | 3 | 2024 | 552 | 0.800 |
Why?
|
| Infant, Premature | 10 | 2023 | 2106 | 0.790 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 2022 | 30 | 0.790 |
Why?
|
| Malabsorption Syndromes | 5 | 2019 | 135 | 0.780 |
Why?
|
| Acidosis | 1 | 2023 | 269 | 0.770 |
Why?
|
| Male | 191 | 2024 | 360703 | 0.760 |
Why?
|
| Pediatrics | 9 | 2021 | 3590 | 0.760 |
Why?
|
| Pregnancy Complications, Hematologic | 4 | 2019 | 180 | 0.760 |
Why?
|
| Methylmalonic Acid | 3 | 2017 | 49 | 0.760 |
Why?
|
| Catheterization, Central Venous | 4 | 2015 | 526 | 0.750 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 8 | 2015 | 5666 | 0.740 |
Why?
|
| Pregnancy Complications | 8 | 2023 | 2949 | 0.740 |
Why?
|
| Infant Formula | 2 | 2022 | 194 | 0.740 |
Why?
|
| Gastrointestinal Agents | 4 | 2017 | 509 | 0.740 |
Why?
|
| Inflammation | 9 | 2024 | 10759 | 0.730 |
Why?
|
| Lipopolysaccharides | 4 | 2018 | 2199 | 0.730 |
Why?
|
| Rural Population | 5 | 2020 | 2277 | 0.720 |
Why?
|
| Hunger | 1 | 2022 | 205 | 0.720 |
Why?
|
| Child Nutrition Disorders | 7 | 2021 | 139 | 0.720 |
Why?
|
| Iron, Dietary | 5 | 2014 | 148 | 0.700 |
Why?
|
| Serial Publications | 1 | 2020 | 11 | 0.690 |
Why?
|
| Mucositis | 2 | 2014 | 108 | 0.690 |
Why?
|
| Vitamin A | 9 | 2020 | 612 | 0.680 |
Why?
|
| India | 17 | 2024 | 2287 | 0.670 |
Why?
|
| Enteritis | 3 | 2018 | 162 | 0.650 |
Why?
|
| Copper | 1 | 2022 | 366 | 0.650 |
Why?
|
| Parenteral Nutrition, Total | 6 | 2022 | 304 | 0.640 |
Why?
|
| Rest | 4 | 2014 | 920 | 0.630 |
Why?
|
| Dietary Proteins | 10 | 2021 | 951 | 0.630 |
Why?
|
| Risk Factors | 65 | 2024 | 74241 | 0.610 |
Why?
|
| Digestive System Surgical Procedures | 8 | 2014 | 571 | 0.610 |
Why?
|
| Editorial Policies | 3 | 2021 | 458 | 0.610 |
Why?
|
| Electric Impedance | 3 | 2023 | 756 | 0.610 |
Why?
|
| Birth Weight | 17 | 2023 | 2104 | 0.610 |
Why?
|
| Prenatal Care | 10 | 2023 | 1141 | 0.600 |
Why?
|
| Blind Loop Syndrome | 1 | 2017 | 4 | 0.600 |
Why?
|
| Vitamin E Deficiency | 2 | 2017 | 30 | 0.600 |
Why?
|
| Food Hypersensitivity | 2 | 2022 | 726 | 0.600 |
Why?
|
| Bacteremia | 3 | 2015 | 978 | 0.590 |
Why?
|
| Trace Elements | 2 | 2016 | 193 | 0.580 |
Why?
|
| Liberia | 5 | 2024 | 174 | 0.570 |
Why?
|
| Hospitals, Pediatric | 6 | 2022 | 1862 | 0.560 |
Why?
|
| Failure to Thrive | 1 | 2018 | 140 | 0.560 |
Why?
|
| Diet | 16 | 2023 | 8048 | 0.560 |
Why?
|
| Developing Countries | 7 | 2022 | 2863 | 0.560 |
Why?
|
| HIV Seropositivity | 2 | 2012 | 957 | 0.560 |
Why?
|
| Socioeconomic Factors | 15 | 2023 | 7804 | 0.560 |
Why?
|
| Cholestasis | 10 | 2015 | 378 | 0.560 |
Why?
|
| Adolescent | 77 | 2023 | 88300 | 0.550 |
Why?
|
| Gastrointestinal Motility | 3 | 2017 | 233 | 0.540 |
Why?
|
| Respiratory Tract Infections | 5 | 2017 | 1009 | 0.540 |
Why?
|
| Mothers | 9 | 2023 | 2193 | 0.540 |
Why?
|
| Soybean Oil | 5 | 2020 | 139 | 0.520 |
Why?
|
| Infant Nutrition Disorders | 4 | 2018 | 70 | 0.520 |
Why?
|
| Anemia, Hemolytic | 1 | 2017 | 163 | 0.510 |
Why?
|
| Infant Food | 5 | 2022 | 139 | 0.500 |
Why?
|
| Respiratory Tract Diseases | 2 | 2018 | 748 | 0.500 |
Why?
|
| Young Adult | 49 | 2024 | 59222 | 0.490 |
Why?
|
| Family | 5 | 2018 | 3192 | 0.480 |
Why?
|
| Infant, Small for Gestational Age | 8 | 2024 | 463 | 0.470 |
Why?
|
| Gastritis | 1 | 2016 | 199 | 0.470 |
Why?
|
| Dysentery | 2 | 2024 | 14 | 0.470 |
Why?
|
| Cognition | 9 | 2019 | 6988 | 0.470 |
Why?
|
| Cholera | 1 | 2021 | 747 | 0.470 |
Why?
|
| Pancreatitis, Chronic | 1 | 2017 | 280 | 0.470 |
Why?
|
| Deuterium | 1 | 2014 | 106 | 0.460 |
Why?
|
| Uganda | 6 | 2021 | 1332 | 0.460 |
Why?
|
| Choline | 5 | 2022 | 515 | 0.460 |
Why?
|
| Intestinal Absorption | 6 | 2022 | 400 | 0.450 |
Why?
|
| Alcohol Drinking | 7 | 2022 | 4027 | 0.450 |
Why?
|
| Follow-Up Studies | 38 | 2019 | 39127 | 0.450 |
Why?
|
| Cohort Studies | 37 | 2024 | 41496 | 0.450 |
Why?
|
| International Educational Exchange | 1 | 2014 | 49 | 0.450 |
Why?
|
| Gestational Age | 11 | 2021 | 3580 | 0.450 |
Why?
|
| Patient Readmission | 4 | 2023 | 3265 | 0.440 |
Why?
|
| Adipose Tissue | 5 | 2023 | 3313 | 0.430 |
Why?
|
| Education, Graduate | 1 | 2014 | 75 | 0.430 |
Why?
|
| Anti-HIV Agents | 12 | 2019 | 4527 | 0.430 |
Why?
|
| Adult | 92 | 2024 | 221120 | 0.430 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 4 | 2020 | 160 | 0.430 |
Why?
|
| Cisapride | 2 | 2011 | 22 | 0.420 |
Why?
|
| Carbon Dioxide | 3 | 2015 | 1147 | 0.420 |
Why?
|
| Psychiatry | 2 | 2022 | 1699 | 0.420 |
Why?
|
| History, 20th Century | 5 | 2022 | 2765 | 0.410 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2015 | 830 | 0.410 |
Why?
|
| Duodenoscopy | 1 | 2012 | 45 | 0.410 |
Why?
|
| Fetal Development | 4 | 2019 | 768 | 0.410 |
Why?
|
| Pregnancy Outcome | 11 | 2023 | 2923 | 0.400 |
Why?
|
| Gastrointestinal Contents | 1 | 2012 | 42 | 0.400 |
Why?
|
| Treatment Outcome | 52 | 2024 | 64681 | 0.400 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 149 | 0.390 |
Why?
|
| Fetal Growth Retardation | 3 | 2022 | 580 | 0.390 |
Why?
|
| Duodenum | 3 | 2012 | 491 | 0.390 |
Why?
|
| Body Fluid Compartments | 1 | 2011 | 50 | 0.390 |
Why?
|
| Eosinophilia | 1 | 2016 | 557 | 0.390 |
Why?
|
| Absorptiometry, Photon | 5 | 2023 | 1738 | 0.380 |
Why?
|
| Overnutrition | 1 | 2011 | 25 | 0.380 |
Why?
|
| Food | 2 | 2009 | 768 | 0.380 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 941 | 0.380 |
Why?
|
| Mouth Mucosa | 1 | 2014 | 432 | 0.380 |
Why?
|
| Jejunostomy | 1 | 2011 | 59 | 0.370 |
Why?
|
| Phosphorus | 1 | 2012 | 332 | 0.370 |
Why?
|
| Cryptosporidium | 2 | 2024 | 41 | 0.360 |
Why?
|
| Vitamin B Complex | 3 | 2019 | 299 | 0.360 |
Why?
|
| Peptic Ulcer | 2 | 2024 | 216 | 0.360 |
Why?
|
| Nervous System | 1 | 2014 | 545 | 0.360 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 2317 | 0.360 |
Why?
|
| Morbidity | 7 | 2024 | 1751 | 0.360 |
Why?
|
| Length of Stay | 10 | 2024 | 6417 | 0.360 |
Why?
|
| Shigella | 2 | 2024 | 68 | 0.360 |
Why?
|
| Immunoglobulin G | 5 | 2023 | 4537 | 0.350 |
Why?
|
| Kwashiorkor | 2 | 2021 | 24 | 0.350 |
Why?
|
| Ribavirin | 1 | 2012 | 394 | 0.350 |
Why?
|
| Glutamine | 3 | 2004 | 574 | 0.350 |
Why?
|
| Prevalence | 19 | 2023 | 15721 | 0.340 |
Why?
|
| Brain Diseases | 1 | 2019 | 1545 | 0.340 |
Why?
|
| Hemoglobins | 8 | 2022 | 1525 | 0.340 |
Why?
|
| Cross Infection | 7 | 2020 | 1422 | 0.340 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1885 | 0.330 |
Why?
|
| Vitamin D | 8 | 2022 | 3301 | 0.330 |
Why?
|
| Calcium, Dietary | 1 | 2012 | 529 | 0.320 |
Why?
|
| Multivariate Analysis | 15 | 2021 | 12052 | 0.320 |
Why?
|
| Incidence | 17 | 2018 | 21366 | 0.320 |
Why?
|
| Hospitalization | 10 | 2024 | 10707 | 0.320 |
Why?
|
| Body Mass Index | 13 | 2023 | 12952 | 0.310 |
Why?
|
| Antidiarrheals | 3 | 2020 | 46 | 0.310 |
Why?
|
| Weight Loss | 3 | 2018 | 2680 | 0.310 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2024 | 876 | 0.310 |
Why?
|
| Malaria, Falciparum | 4 | 2017 | 1076 | 0.310 |
Why?
|
| Graft vs Host Disease | 2 | 2014 | 3025 | 0.310 |
Why?
|
| Intestinal Atresia | 7 | 2014 | 68 | 0.300 |
Why?
|
| Longitudinal Studies | 12 | 2022 | 14610 | 0.300 |
Why?
|
| Time Factors | 26 | 2024 | 39957 | 0.300 |
Why?
|
| Gastroschisis | 8 | 2014 | 99 | 0.300 |
Why?
|
| Milk, Human | 5 | 2022 | 486 | 0.300 |
Why?
|
| Retrospective Studies | 38 | 2024 | 80675 | 0.300 |
Why?
|
| Interferon-alpha | 1 | 2012 | 907 | 0.300 |
Why?
|
| Depressive Disorder | 8 | 2001 | 3727 | 0.300 |
Why?
|
| Dietary Carbohydrates | 5 | 2018 | 891 | 0.300 |
Why?
|
| Respiration, Artificial | 7 | 2016 | 2631 | 0.290 |
Why?
|
| Fatty Acids, Essential | 2 | 2005 | 97 | 0.280 |
Why?
|
| Scurvy | 1 | 2007 | 36 | 0.280 |
Why?
|
| Pilot Projects | 12 | 2024 | 8642 | 0.280 |
Why?
|
| Environment | 3 | 2018 | 1122 | 0.270 |
Why?
|
| Bone Density | 4 | 2015 | 3546 | 0.270 |
Why?
|
| Infection Control | 2 | 2012 | 983 | 0.270 |
Why?
|
| Environmental Exposure | 3 | 2017 | 4479 | 0.270 |
Why?
|
| Adolescent Development | 2 | 2021 | 282 | 0.270 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 1187 | 0.270 |
Why?
|
| Ileocecal Valve | 3 | 2015 | 22 | 0.260 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2024 | 1116 | 0.260 |
Why?
|
| Bacterial Infections | 2 | 2024 | 1390 | 0.260 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 20118 | 0.260 |
Why?
|
| Fontan Procedure | 1 | 2012 | 796 | 0.250 |
Why?
|
| Liver Cirrhosis | 5 | 2015 | 1932 | 0.250 |
Why?
|
| Publishing | 3 | 2021 | 832 | 0.250 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1867 | 0.250 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 13632 | 0.250 |
Why?
|
| Ferritins | 5 | 2023 | 596 | 0.250 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2008 | 268 | 0.250 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 4673 | 0.250 |
Why?
|
| Osteoporosis | 1 | 2015 | 1604 | 0.240 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1212 | 0.240 |
Why?
|
| Antiretroviral Therapy, Highly Active | 6 | 2019 | 1895 | 0.240 |
Why?
|
| Skinfold Thickness | 3 | 2017 | 163 | 0.240 |
Why?
|
| Age Factors | 14 | 2018 | 18384 | 0.240 |
Why?
|
| Rotavirus | 2 | 2017 | 109 | 0.230 |
Why?
|
| Lactic Acid | 3 | 2023 | 1139 | 0.230 |
Why?
|
| Potassium Chloride | 2 | 2004 | 229 | 0.230 |
Why?
|
| Antacids | 2 | 2016 | 94 | 0.230 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2008 | 354 | 0.230 |
Why?
|
| Vitamin A Deficiency | 4 | 2017 | 88 | 0.230 |
Why?
|
| Poverty | 4 | 2022 | 2691 | 0.230 |
Why?
|
| Pregnant Women | 4 | 2023 | 568 | 0.230 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2024 | 30 | 0.230 |
Why?
|
| Gastroenteritis | 3 | 2014 | 236 | 0.230 |
Why?
|
| Hepatitis C, Chronic | 1 | 2012 | 1027 | 0.230 |
Why?
|
| Azithromycin | 2 | 2024 | 199 | 0.230 |
Why?
|
| Anemia, Hypochromic | 3 | 2012 | 63 | 0.230 |
Why?
|
| Cryptosporidiosis | 1 | 2024 | 52 | 0.220 |
Why?
|
| Motor Skills | 2 | 2019 | 521 | 0.220 |
Why?
|
| Dietary Fats | 4 | 2018 | 1994 | 0.220 |
Why?
|
| Bicarbonates | 2 | 2004 | 292 | 0.220 |
Why?
|
| Bacteria | 3 | 2024 | 2190 | 0.220 |
Why?
|
| Nutrition Assessment | 7 | 2018 | 727 | 0.220 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2003 | 62 | 0.220 |
Why?
|
| Cachexia | 2 | 2023 | 202 | 0.220 |
Why?
|
| C-Reactive Protein | 5 | 2024 | 3821 | 0.210 |
Why?
|
| Plethysmography | 1 | 2023 | 174 | 0.210 |
Why?
|
| Permeability | 4 | 2019 | 721 | 0.210 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2023 | 45 | 0.210 |
Why?
|
| Bangladesh | 2 | 2016 | 732 | 0.210 |
Why?
|
| Radiotherapy | 1 | 2010 | 1500 | 0.210 |
Why?
|
| Logistic Models | 12 | 2016 | 13249 | 0.210 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 2002 | 15 | 0.210 |
Why?
|
| Cross-Sectional Studies | 18 | 2024 | 26072 | 0.200 |
Why?
|
| United States | 16 | 2024 | 72341 | 0.200 |
Why?
|
| Sodium Chloride | 2 | 2004 | 584 | 0.200 |
Why?
|
| Placenta | 3 | 2022 | 1711 | 0.200 |
Why?
|
| Health Education | 3 | 2022 | 1049 | 0.200 |
Why?
|
| Chorioamnionitis | 1 | 2023 | 156 | 0.200 |
Why?
|
| Pregnancy Trimester, First | 4 | 2018 | 908 | 0.200 |
Why?
|
| Amino Acids, Sulfur | 1 | 2021 | 16 | 0.200 |
Why?
|
| Vitamin E | 3 | 2017 | 872 | 0.200 |
Why?
|
| Consensus | 2 | 2024 | 3134 | 0.190 |
Why?
|
| Acute Disease | 15 | 2021 | 7226 | 0.190 |
Why?
|
| Hypoproteinemia | 1 | 2021 | 11 | 0.190 |
Why?
|
| Research Design | 7 | 2021 | 6180 | 0.190 |
Why?
|
| Vitamin K | 1 | 2004 | 313 | 0.190 |
Why?
|
| Hirschsprung Disease | 3 | 2012 | 163 | 0.190 |
Why?
|
| Placebos | 4 | 2017 | 1666 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2017 | 8479 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 12 | 2024 | 10218 | 0.190 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2024 | 477 | 0.190 |
Why?
|
| Reference Values | 7 | 2013 | 4921 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2014 | 3434 | 0.190 |
Why?
|
| Liver | 6 | 2021 | 7512 | 0.190 |
Why?
|
| Proportional Hazards Models | 9 | 2018 | 12474 | 0.190 |
Why?
|
| Folic Acid | 5 | 2016 | 1323 | 0.190 |
Why?
|
| Nutritional Support | 3 | 2009 | 173 | 0.190 |
Why?
|
| Weight Gain | 6 | 2019 | 2349 | 0.180 |
Why?
|
| Bibliometrics | 2 | 2021 | 352 | 0.180 |
Why?
|
| Feeding Behavior | 3 | 2021 | 3183 | 0.180 |
Why?
|
| Oligosaccharides | 1 | 2003 | 406 | 0.180 |
Why?
|
| Methionine | 3 | 2021 | 570 | 0.180 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2006 | 594 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 7 | 2024 | 7407 | 0.170 |
Why?
|
| Arm | 2 | 2018 | 589 | 0.170 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3813 | 0.170 |
Why?
|
| Hygiene | 2 | 2018 | 94 | 0.170 |
Why?
|
| Neurotic Disorders | 2 | 1998 | 77 | 0.170 |
Why?
|
| Anti-Ulcer Agents | 1 | 2020 | 112 | 0.170 |
Why?
|
| Students, Medical | 2 | 2024 | 1940 | 0.160 |
Why?
|
| Stillbirth | 4 | 2023 | 369 | 0.160 |
Why?
|
| Administration, Oral | 4 | 2021 | 4015 | 0.160 |
Why?
|
| Malaria | 5 | 2015 | 1225 | 0.160 |
Why?
|
| Cystic Fibrosis | 4 | 2009 | 1283 | 0.160 |
Why?
|
| Odds Ratio | 9 | 2018 | 9652 | 0.160 |
Why?
|
| Jejunum | 2 | 2014 | 472 | 0.160 |
Why?
|
| Hypercalcemia | 1 | 2022 | 423 | 0.160 |
Why?
|
| Sex Factors | 6 | 2018 | 10553 | 0.160 |
Why?
|
| Aflatoxins | 1 | 2018 | 12 | 0.160 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 166 | 0.160 |
Why?
|
| Prothrombin | 1 | 1999 | 192 | 0.160 |
Why?
|
| Pregnancy Complications, Parasitic | 2 | 2017 | 61 | 0.160 |
Why?
|
| Linear Models | 6 | 2021 | 5869 | 0.160 |
Why?
|
| Hematologic Tests | 1 | 2020 | 239 | 0.160 |
Why?
|
| Orosomucoid | 1 | 2018 | 45 | 0.160 |
Why?
|
| Factor V | 1 | 1999 | 168 | 0.160 |
Why?
|
| Home Care Services | 2 | 2015 | 647 | 0.160 |
Why?
|
| Intelligence | 2 | 2021 | 922 | 0.160 |
Why?
|
| Gastrostomy | 3 | 2014 | 323 | 0.160 |
Why?
|
| Postoperative Period | 4 | 2015 | 1818 | 0.150 |
Why?
|
| Breath Tests | 2 | 2010 | 299 | 0.150 |
Why?
|
| Authorship | 1 | 2021 | 284 | 0.150 |
Why?
|
| Albumins | 1 | 2021 | 575 | 0.150 |
Why?
|
| Postoperative Complications | 8 | 2024 | 15637 | 0.150 |
Why?
|
| Stem Cell Transplantation | 2 | 2004 | 1600 | 0.150 |
Why?
|
| Ascorbic Acid | 2 | 2014 | 654 | 0.150 |
Why?
|
| Patient Care Team | 2 | 2017 | 2515 | 0.150 |
Why?
|
| Mental Disorders | 2 | 2012 | 6823 | 0.150 |
Why?
|
| Gastroparesis | 1 | 2020 | 138 | 0.150 |
Why?
|
| Water Microbiology | 1 | 2018 | 113 | 0.150 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 583 | 0.150 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2019 | 149 | 0.150 |
Why?
|
| Community Health Services | 1 | 2003 | 655 | 0.150 |
Why?
|
| Malawi | 3 | 2024 | 300 | 0.150 |
Why?
|
| Counseling | 3 | 2022 | 1536 | 0.150 |
Why?
|
| HIV-1 | 6 | 2016 | 6851 | 0.150 |
Why?
|
| Hospitals, Teaching | 1 | 2002 | 1155 | 0.150 |
Why?
|
| Blinking | 1 | 2018 | 133 | 0.150 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 1999 | 220 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 2 | 2017 | 710 | 0.140 |
Why?
|
| Food Contamination | 1 | 2018 | 191 | 0.140 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 1997 | 19 | 0.140 |
Why?
|
| Bilirubin | 4 | 2015 | 436 | 0.140 |
Why?
|
| Language Development | 2 | 2019 | 183 | 0.140 |
Why?
|
| Gastrointestinal Tract | 3 | 2014 | 834 | 0.140 |
Why?
|
| Campylobacter | 1 | 2017 | 57 | 0.140 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2017 | 26 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2007 | 2911 | 0.140 |
Why?
|
| Feces | 4 | 2019 | 1490 | 0.140 |
Why?
|
| Vomiting | 3 | 2020 | 650 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 3 | 2005 | 2692 | 0.140 |
Why?
|
| Water-Electrolyte Balance | 2 | 2012 | 325 | 0.140 |
Why?
|
| Family Health | 2 | 1998 | 1254 | 0.140 |
Why?
|
| Gender Identity | 1 | 2023 | 766 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2007 | 2568 | 0.140 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 1702 | 0.140 |
Why?
|
| Social Support | 4 | 2023 | 2175 | 0.140 |
Why?
|
| Trypsin | 1 | 2017 | 486 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 415 | 0.130 |
Why?
|
| Income | 2 | 2022 | 1869 | 0.130 |
Why?
|
| Food Supply | 2 | 2020 | 539 | 0.130 |
Why?
|
| Personality Inventory | 2 | 1998 | 1018 | 0.130 |
Why?
|
| Neoplasms | 3 | 2024 | 22142 | 0.130 |
Why?
|
| Glucose | 4 | 2017 | 4342 | 0.130 |
Why?
|
| Fatty Liver | 2 | 2013 | 789 | 0.130 |
Why?
|
| Liver Function Tests | 4 | 2010 | 525 | 0.130 |
Why?
|
| Pregnancy Trimesters | 1 | 2017 | 197 | 0.130 |
Why?
|
| Attitude | 1 | 2001 | 771 | 0.130 |
Why?
|
| Critical Care | 3 | 2014 | 2696 | 0.130 |
Why?
|
| Cloaca | 1 | 2016 | 52 | 0.130 |
Why?
|
| Quality Improvement | 2 | 2023 | 3808 | 0.130 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2021 | 518 | 0.130 |
Why?
|
| Quality of Life | 4 | 2024 | 13367 | 0.130 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 12976 | 0.130 |
Why?
|
| Disclosure | 1 | 2021 | 747 | 0.130 |
Why?
|
| Diet, Fat-Restricted | 1 | 1998 | 329 | 0.130 |
Why?
|
| Homocysteine | 2 | 2016 | 637 | 0.130 |
Why?
|
| Pediatric Nursing | 1 | 1996 | 104 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2022 | 1567 | 0.130 |
Why?
|
| Calcium | 4 | 2024 | 5719 | 0.130 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2015 | 379 | 0.130 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 153 | 0.130 |
Why?
|
| Nutrition Surveys | 3 | 2017 | 1723 | 0.130 |
Why?
|
| Housing | 1 | 2020 | 669 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17897 | 0.120 |
Why?
|
| Food, Formulated | 3 | 2001 | 101 | 0.120 |
Why?
|
| Hepatic Insufficiency | 1 | 2015 | 14 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2015 | 2570 | 0.120 |
Why?
|
| Executive Function | 2 | 2021 | 1388 | 0.120 |
Why?
|
| Lost to Follow-Up | 1 | 2015 | 123 | 0.120 |
Why?
|
| Postoperative Care | 3 | 2014 | 1468 | 0.120 |
Why?
|
| Homeopathy | 1 | 1994 | 30 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2022 | 1933 | 0.120 |
Why?
|
| Minority Groups | 1 | 2022 | 1201 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 2020 | 1176 | 0.120 |
Why?
|
| Bladder Exstrophy | 1 | 2016 | 106 | 0.120 |
Why?
|
| Case-Control Studies | 7 | 2023 | 22174 | 0.120 |
Why?
|
| Stomach | 1 | 1999 | 697 | 0.120 |
Why?
|
| Lamivudine | 1 | 2016 | 366 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2024 | 1233 | 0.120 |
Why?
|
| Severity of Illness Index | 9 | 2016 | 15841 | 0.110 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 4822 | 0.110 |
Why?
|
| Education, Medical | 3 | 2024 | 1725 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2022 | 1807 | 0.110 |
Why?
|
| South Africa | 4 | 2022 | 1843 | 0.110 |
Why?
|
| Aspartate Aminotransferases | 2 | 2013 | 411 | 0.110 |
Why?
|
| Mathematical Concepts | 1 | 2014 | 73 | 0.110 |
Why?
|
| Rotavirus Vaccines | 1 | 2014 | 62 | 0.110 |
Why?
|
| Gastric Fistula | 1 | 2014 | 73 | 0.110 |
Why?
|
| Parenting | 2 | 2009 | 701 | 0.110 |
Why?
|
| Skin | 1 | 2007 | 4473 | 0.110 |
Why?
|
| Diseases in Twins | 1 | 1995 | 446 | 0.110 |
Why?
|
| Rotavirus Infections | 1 | 2014 | 84 | 0.110 |
Why?
|
| Lactulose | 3 | 2018 | 31 | 0.110 |
Why?
|
| Avitaminosis | 1 | 2013 | 35 | 0.110 |
Why?
|
| Cholagogues and Choleretics | 1 | 2013 | 39 | 0.110 |
Why?
|
| Insulin | 3 | 2015 | 6588 | 0.110 |
Why?
|
| Depression | 4 | 2023 | 8132 | 0.110 |
Why?
|
| Intestinal Obstruction | 2 | 2003 | 432 | 0.110 |
Why?
|
| Osmolar Concentration | 3 | 2004 | 659 | 0.110 |
Why?
|
| Hospital Mortality | 3 | 2024 | 5295 | 0.110 |
Why?
|
| Body Water | 1 | 2014 | 340 | 0.110 |
Why?
|
| Defecation | 1 | 2014 | 190 | 0.110 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2013 | 81 | 0.110 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2015 | 407 | 0.100 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 279 | 0.100 |
Why?
|
| Measles Vaccine | 1 | 2013 | 79 | 0.100 |
Why?
|
| Chloroquine | 2 | 2005 | 274 | 0.100 |
Why?
|
| Swimming | 1 | 2013 | 208 | 0.100 |
Why?
|
| Mannitol | 3 | 2018 | 177 | 0.100 |
Why?
|
| Antibodies, Viral | 2 | 2014 | 3149 | 0.100 |
Why?
|
| Orphanages | 1 | 2012 | 34 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 3 | 2017 | 6067 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 4947 | 0.100 |
Why?
|
| HIV Seronegativity | 1 | 2012 | 211 | 0.100 |
Why?
|
| Indians, North American | 1 | 2015 | 351 | 0.100 |
Why?
|
| Bacterial Load | 1 | 2012 | 150 | 0.100 |
Why?
|
| Social Class | 1 | 2020 | 1993 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 1995 | 767 | 0.100 |
Why?
|
| Oral Health | 1 | 1997 | 491 | 0.100 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2011 | 64 | 0.090 |
Why?
|
| Exercise | 2 | 2022 | 5874 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2018 | 1067 | 0.090 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 3089 | 0.090 |
Why?
|
| Health Promotion | 1 | 2023 | 2205 | 0.090 |
Why?
|
| Medication Errors | 1 | 2017 | 783 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 3200 | 0.090 |
Why?
|
| Alanine Transaminase | 3 | 2009 | 602 | 0.090 |
Why?
|
| Poverty Areas | 1 | 2012 | 263 | 0.090 |
Why?
|
| Mucous Membrane | 1 | 2014 | 659 | 0.090 |
Why?
|
| Suction | 1 | 2012 | 266 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2018 | 1390 | 0.090 |
Why?
|
| Recurrence | 4 | 2017 | 8457 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2018 | 4014 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 410 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 10756 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 14675 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 1510 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 4 | 2013 | 1784 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 7400 | 0.090 |
Why?
|
| Ethanol | 2 | 2022 | 1322 | 0.090 |
Why?
|
| Homeostasis | 1 | 2021 | 3322 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 1997 | 1791 | 0.090 |
Why?
|
| Africa South of the Sahara | 2 | 2024 | 745 | 0.090 |
Why?
|
| Democratic Republic of the Congo | 2 | 2021 | 86 | 0.090 |
Why?
|
| Antimalarials | 3 | 2012 | 907 | 0.090 |
Why?
|
| Education, Distance | 1 | 2014 | 260 | 0.090 |
Why?
|
| Health Priorities | 1 | 2013 | 375 | 0.090 |
Why?
|
| Risk | 5 | 2018 | 9616 | 0.090 |
Why?
|
| Postpartum Period | 2 | 2016 | 1178 | 0.090 |
Why?
|
| Food, Fortified | 2 | 2019 | 189 | 0.090 |
Why?
|
| Eating | 2 | 2012 | 1535 | 0.090 |
Why?
|
| Carbon Isotopes | 1 | 2010 | 458 | 0.080 |
Why?
|
| Obesity | 4 | 2016 | 12940 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2013 | 485 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2015 | 6392 | 0.080 |
Why?
|
| Regression Analysis | 5 | 2018 | 6345 | 0.080 |
Why?
|
| Brain | 1 | 2016 | 27094 | 0.080 |
Why?
|
| Risk Assessment | 8 | 2024 | 24022 | 0.080 |
Why?
|
| Monitoring, Physiologic | 2 | 2014 | 1780 | 0.080 |
Why?
|
| Meat | 1 | 2012 | 584 | 0.080 |
Why?
|
| Tuberculosis | 2 | 2012 | 2017 | 0.080 |
Why?
|
| Boston | 4 | 2015 | 9327 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2024 | 4788 | 0.080 |
Why?
|
| Probiotics | 2 | 2003 | 378 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 1423 | 0.080 |
Why?
|
| Data Collection | 1 | 1998 | 3320 | 0.080 |
Why?
|
| Genetic Variation | 2 | 2020 | 6567 | 0.080 |
Why?
|
| Nutrition Policy | 1 | 2012 | 466 | 0.080 |
Why?
|
| Parasitemia | 2 | 2012 | 165 | 0.080 |
Why?
|
| Visual Acuity | 1 | 2018 | 2676 | 0.080 |
Why?
|
| Stress, Physiological | 2 | 2011 | 1405 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3608 | 0.070 |
Why?
|
| Gingival Hypertrophy | 1 | 2007 | 5 | 0.070 |
Why?
|
| Pakistan | 2 | 2019 | 292 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 247 | 0.070 |
Why?
|
| Enterocytes | 1 | 2009 | 220 | 0.070 |
Why?
|
| Siblings | 1 | 2012 | 824 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 328 | 0.070 |
Why?
|
| Child Welfare | 1 | 2012 | 521 | 0.070 |
Why?
|
| Peru | 2 | 2018 | 888 | 0.070 |
Why?
|
| Child Health Services | 1 | 2013 | 644 | 0.070 |
Why?
|
| Mammography | 1 | 2018 | 2430 | 0.070 |
Why?
|
| Mental Health | 2 | 2019 | 3251 | 0.070 |
Why?
|
| Research | 2 | 2009 | 1976 | 0.070 |
Why?
|
| Adiponectin | 1 | 2013 | 1107 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 3691 | 0.070 |
Why?
|
| Feasibility Studies | 4 | 2024 | 5250 | 0.070 |
Why?
|
| Educational Status | 2 | 2012 | 2510 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2016 | 1936 | 0.070 |
Why?
|
| Hematologic Neoplasms | 2 | 2012 | 1895 | 0.070 |
Why?
|
| Spine | 1 | 2013 | 1129 | 0.070 |
Why?
|
| Syndrome | 2 | 2016 | 3271 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 1232 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2018 | 4201 | 0.070 |
Why?
|
| Endoscopy | 1 | 2016 | 1852 | 0.070 |
Why?
|
| Curriculum | 2 | 2024 | 3741 | 0.070 |
Why?
|
| Lung Diseases | 1 | 1996 | 1910 | 0.070 |
Why?
|
| Predictive Value of Tests | 5 | 2010 | 15308 | 0.070 |
Why?
|
| Visual Field Tests | 2 | 1985 | 411 | 0.070 |
Why?
|
| Inpatients | 1 | 2017 | 2545 | 0.070 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2005 | 19 | 0.060 |
Why?
|
| Probability | 2 | 2008 | 2478 | 0.060 |
Why?
|
| Health Services Research | 1 | 2013 | 1807 | 0.060 |
Why?
|
| Ileum | 1 | 2008 | 557 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2017 | 7965 | 0.060 |
Why?
|
| Students | 1 | 2015 | 1737 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2854 | 0.060 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 20982 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2024 | 3627 | 0.060 |
Why?
|
| Hyperbilirubinemia | 1 | 2005 | 74 | 0.060 |
Why?
|
| Phenotype | 2 | 2020 | 16575 | 0.060 |
Why?
|
| Prognosis | 8 | 2015 | 29688 | 0.060 |
Why?
|
| Fever | 1 | 2012 | 1618 | 0.060 |
Why?
|
| Leptin | 1 | 2013 | 1595 | 0.060 |
Why?
|
| Cerebral Palsy | 2 | 2001 | 477 | 0.060 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 1164 | 0.060 |
Why?
|
| Postnatal Care | 2 | 2019 | 260 | 0.060 |
Why?
|
| Antitubercular Agents | 1 | 2013 | 1374 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2009 | 697 | 0.060 |
Why?
|
| Peptides | 1 | 2016 | 4353 | 0.060 |
Why?
|
| Carcinoma in Situ | 1 | 2010 | 791 | 0.060 |
Why?
|
| Adiposity | 1 | 2014 | 1879 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1375 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3210 | 0.060 |
Why?
|
| Calreticulin | 1 | 2005 | 113 | 0.060 |
Why?
|
| Bottle Feeding | 2 | 2010 | 67 | 0.060 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 3031 | 0.060 |
Why?
|
| Rickets | 1 | 2004 | 70 | 0.060 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2004 | 84 | 0.060 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 931 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2009 | 875 | 0.060 |
Why?
|
| Family Characteristics | 2 | 2018 | 992 | 0.060 |
Why?
|
| Permethrin | 1 | 2003 | 15 | 0.050 |
Why?
|
| Aquaculture | 1 | 2023 | 28 | 0.050 |
Why?
|
| Haemophilus influenzae type b | 1 | 2003 | 16 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2007 | 407 | 0.050 |
Why?
|
| Haemophilus Vaccines | 1 | 2003 | 71 | 0.050 |
Why?
|
| Psychotherapy | 3 | 2001 | 1646 | 0.050 |
Why?
|
| Bedding and Linens | 1 | 2003 | 41 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2017 | 10088 | 0.050 |
Why?
|
| Asia | 1 | 2024 | 622 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 1084 | 0.050 |
Why?
|
| Fisheries | 1 | 2023 | 48 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2013 | 2477 | 0.050 |
Why?
|
| Exanthema | 1 | 2007 | 503 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6504 | 0.050 |
Why?
|
| Lipase | 1 | 2004 | 320 | 0.050 |
Why?
|
| Fetal Death | 1 | 2024 | 435 | 0.050 |
Why?
|
| Ulcer | 1 | 2024 | 204 | 0.050 |
Why?
|
| Drug Administration Schedule | 3 | 2021 | 4851 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2011 | 2489 | 0.050 |
Why?
|
| Health Behavior | 2 | 2013 | 2641 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6304 | 0.050 |
Why?
|
| Child, Hospitalized | 1 | 2023 | 182 | 0.050 |
Why?
|
| Myosin Type II | 1 | 2002 | 70 | 0.050 |
Why?
|
| Manihot | 1 | 2021 | 4 | 0.050 |
Why?
|
| Molecular Motor Proteins | 1 | 2002 | 106 | 0.050 |
Why?
|
| Egypt | 3 | 1996 | 98 | 0.050 |
Why?
|
| Insecticides | 1 | 2003 | 193 | 0.050 |
Why?
|
| Animals | 8 | 2022 | 168089 | 0.050 |
Why?
|
| Liver Failure | 2 | 2017 | 250 | 0.050 |
Why?
|
| Safety | 2 | 2005 | 1151 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 2018 | 1624 | 0.050 |
Why?
|
| Peanut Hypersensitivity | 1 | 2004 | 219 | 0.050 |
Why?
|
| Pathology, Molecular | 1 | 2024 | 329 | 0.050 |
Why?
|
| Receptors, Cell Surface | 3 | 2005 | 2802 | 0.050 |
Why?
|
| Adaptation, Physiological | 2 | 2013 | 1301 | 0.050 |
Why?
|
| Amino Acids | 2 | 2017 | 1703 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2022 | 295 | 0.040 |
Why?
|
| Telemedicine | 1 | 2018 | 3051 | 0.040 |
Why?
|
| Biopsy | 4 | 2015 | 6781 | 0.040 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 2 | 1998 | 75 | 0.040 |
Why?
|
| Treatment Failure | 3 | 2014 | 2643 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2022 | 569 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2001 | 225 | 0.040 |
Why?
|
| Antidepressive Agents | 3 | 2001 | 2893 | 0.040 |
Why?
|
| Rheumatic Diseases | 1 | 2007 | 654 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2008 | 1395 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2012 | 3048 | 0.040 |
Why?
|
| Patient Satisfaction | 3 | 2001 | 3453 | 0.040 |
Why?
|
| Chronic Disease | 3 | 2017 | 9319 | 0.040 |
Why?
|
| England | 1 | 2001 | 526 | 0.040 |
Why?
|
| Mali | 1 | 2019 | 50 | 0.040 |
Why?
|
| Professional Practice | 1 | 2001 | 313 | 0.040 |
Why?
|
| Ranitidine | 1 | 1999 | 34 | 0.040 |
Why?
|
| Radiography | 2 | 2007 | 6974 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2022 | 850 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2017 | 1436 | 0.040 |
Why?
|
| Parturition | 1 | 2023 | 447 | 0.040 |
Why?
|
| Algorithms | 2 | 2014 | 14025 | 0.040 |
Why?
|
| Haptoglobins | 1 | 2020 | 165 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2006 | 1348 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2024 | 3744 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2015 | 1092 | 0.040 |
Why?
|
| Glaucoma | 2 | 1985 | 1186 | 0.040 |
Why?
|
| Immunization | 1 | 2003 | 1218 | 0.040 |
Why?
|
| China | 2 | 2015 | 2374 | 0.040 |
Why?
|
| Visual Fields | 1 | 1985 | 1061 | 0.040 |
Why?
|
| Disease Progression | 2 | 2022 | 13511 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6486 | 0.040 |
Why?
|
| Glutathione | 1 | 2001 | 581 | 0.040 |
Why?
|
| Sanitation | 1 | 2018 | 82 | 0.040 |
Why?
|
| Muscles | 1 | 2003 | 1568 | 0.040 |
Why?
|
| Arginine | 1 | 2002 | 920 | 0.040 |
Why?
|
| Pain | 2 | 2018 | 5072 | 0.040 |
Why?
|
| Middle Aged | 17 | 2018 | 220858 | 0.040 |
Why?
|
| Cross-Over Studies | 3 | 2013 | 2082 | 0.040 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2020 | 264 | 0.040 |
Why?
|
| Gastric Emptying | 1 | 2020 | 243 | 0.040 |
Why?
|
| Overweight | 3 | 2016 | 2418 | 0.040 |
Why?
|
| Absorption | 1 | 1997 | 242 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2007 | 1222 | 0.040 |
Why?
|
| Health Status | 1 | 2011 | 4077 | 0.040 |
Why?
|
| Achievement | 1 | 1999 | 288 | 0.040 |
Why?
|
| Family Practice | 4 | 2001 | 507 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 1998 | 6011 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2001 | 531 | 0.040 |
Why?
|
| Problem-Based Learning | 1 | 2001 | 356 | 0.040 |
Why?
|
| Powders | 1 | 2017 | 80 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2021 | 1161 | 0.040 |
Why?
|
| Documentation | 1 | 2023 | 900 | 0.040 |
Why?
|
| Madagascar | 1 | 2017 | 109 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1998 | 325 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2018 | 131 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1929 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2013 | 1636 | 0.030 |
Why?
|
| Diet Records | 1 | 2018 | 427 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 1464 | 0.030 |
Why?
|
| Universal Precautions | 1 | 1996 | 34 | 0.030 |
Why?
|
| Retinol-Binding Proteins | 1 | 1996 | 67 | 0.030 |
Why?
|
| Electrolytes | 1 | 2017 | 274 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1997 | 416 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2017 | 245 | 0.030 |
Why?
|
| Marital Status | 1 | 1998 | 425 | 0.030 |
Why?
|
| Cysteine | 1 | 2001 | 888 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 1996 | 94 | 0.030 |
Why?
|
| Rural Health | 1 | 2018 | 296 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 4373 | 0.030 |
Why?
|
| Computer Security | 1 | 2018 | 260 | 0.030 |
Why?
|
| Mexico | 1 | 2018 | 757 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2020 | 1132 | 0.030 |
Why?
|
| Videoconferencing | 1 | 2018 | 203 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 1995 | 7865 | 0.030 |
Why?
|
| Methylhistidines | 1 | 2015 | 35 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 278 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 8519 | 0.030 |
Why?
|
| Protoporphyrins | 1 | 2016 | 168 | 0.030 |
Why?
|
| Anus, Imperforate | 1 | 2016 | 63 | 0.030 |
Why?
|
| Methamphetamine | 1 | 2017 | 165 | 0.030 |
Why?
|
| Genitalia | 1 | 2016 | 113 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2006 | 4165 | 0.030 |
Why?
|
| Health Resources | 1 | 2021 | 934 | 0.030 |
Why?
|
| Ileal Diseases | 1 | 1995 | 68 | 0.030 |
Why?
|
| Registries | 2 | 2013 | 8246 | 0.030 |
Why?
|
| Forecasting | 2 | 2015 | 2928 | 0.030 |
Why?
|
| Hypertension | 1 | 2015 | 8536 | 0.030 |
Why?
|
| Gastroscopy | 1 | 1997 | 211 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2006 | 1462 | 0.030 |
Why?
|
| Office Visits | 1 | 1999 | 593 | 0.030 |
Why?
|
| Compassionate Use Trials | 1 | 2015 | 50 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2023 | 1818 | 0.030 |
Why?
|
| Object Attachment | 1 | 1998 | 326 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2015 | 197 | 0.030 |
Why?
|
| Pregnancy, Multiple | 1 | 2015 | 215 | 0.030 |
Why?
|
| Hernia, Umbilical | 1 | 2016 | 102 | 0.030 |
Why?
|
| Maternal Mortality | 1 | 2017 | 301 | 0.030 |
Why?
|
| Receptors, Transferrin | 1 | 2016 | 291 | 0.030 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1995 | 189 | 0.030 |
Why?
|
| Actins | 1 | 2002 | 2046 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2018 | 848 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2012 | 2359 | 0.030 |
Why?
|
| Dairy Products | 1 | 1997 | 490 | 0.030 |
Why?
|
| Growth Substances | 1 | 1996 | 759 | 0.030 |
Why?
|
| Zinc Sulfate | 1 | 2013 | 18 | 0.030 |
Why?
|
| Comorbidity | 3 | 2014 | 10516 | 0.030 |
Why?
|
| Dietary Fiber | 1 | 1997 | 758 | 0.030 |
Why?
|
| Endemic Diseases | 1 | 2014 | 191 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 221 | 0.030 |
Why?
|
| Burkina Faso | 1 | 2013 | 86 | 0.030 |
Why?
|
| Pentamidine | 1 | 1993 | 44 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 371 | 0.030 |
Why?
|
| Teaching | 1 | 2001 | 1171 | 0.030 |
Why?
|
| Placenta Diseases | 1 | 2015 | 199 | 0.030 |
Why?
|
| Laparotomy | 1 | 1995 | 456 | 0.030 |
Why?
|
| Dental Caries | 1 | 1997 | 427 | 0.030 |
Why?
|
| Triglycerides | 2 | 2013 | 2457 | 0.030 |
Why?
|
| Caregivers | 2 | 2017 | 2244 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 1999 | 1472 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 2014 | 227 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2014 | 315 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2019 | 1047 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2023 | 2189 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 30004 | 0.030 |
Why?
|
| Decision Trees | 1 | 2014 | 505 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2013 | 246 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2013 | 144 | 0.030 |
Why?
|
| Home Nursing | 1 | 1992 | 92 | 0.030 |
Why?
|
| Maternal Health Services | 1 | 2017 | 460 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 9278 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2012 | 208 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2013 | 413 | 0.020 |
Why?
|
| Proteins | 1 | 2006 | 5993 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 4190 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 12159 | 0.020 |
Why?
|
| Fasting | 1 | 1997 | 1603 | 0.020 |
Why?
|
| Urban Health | 1 | 2014 | 532 | 0.020 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2015 | 497 | 0.020 |
Why?
|
| Infant Care | 1 | 1992 | 180 | 0.020 |
Why?
|
| Social Problems | 1 | 1991 | 109 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1997 | 1162 | 0.020 |
Why?
|
| Pedigree | 1 | 1998 | 4537 | 0.020 |
Why?
|
| Infant Welfare | 1 | 2011 | 80 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1999 | 6223 | 0.020 |
Why?
|
| Observer Variation | 1 | 1997 | 2610 | 0.020 |
Why?
|
| Palliative Care | 1 | 2006 | 3599 | 0.020 |
Why?
|
| Instillation, Drug | 1 | 2010 | 32 | 0.020 |
Why?
|
| Platelet Count | 1 | 2013 | 782 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2021 | 2770 | 0.020 |
Why?
|
| Erythrocytes | 2 | 2013 | 2413 | 0.020 |
Why?
|
| Sodium | 1 | 1996 | 1589 | 0.020 |
Why?
|
| Antibodies | 1 | 2018 | 2415 | 0.020 |
Why?
|
| Self Care | 1 | 2015 | 795 | 0.020 |
Why?
|
| Iron Overload | 1 | 2012 | 239 | 0.020 |
Why?
|
| Mitochondria, Liver | 1 | 2010 | 190 | 0.020 |
Why?
|
| Maternal Age | 1 | 2013 | 809 | 0.020 |
Why?
|
| Prothrombin Time | 1 | 2010 | 117 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1880 | 0.020 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2010 | 75 | 0.020 |
Why?
|
| Creatinine | 1 | 2015 | 1897 | 0.020 |
Why?
|
| Canada | 1 | 2015 | 2125 | 0.020 |
Why?
|
| Parity | 1 | 2013 | 929 | 0.020 |
Why?
|
| Parents | 2 | 2013 | 3564 | 0.020 |
Why?
|
| Maternal Welfare | 1 | 2010 | 112 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 1535 | 0.020 |
Why?
|
| Medical Records | 1 | 2015 | 1409 | 0.020 |
Why?
|
| Survival Rate | 2 | 2009 | 12728 | 0.020 |
Why?
|
| Plasmodium | 1 | 2012 | 246 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 9478 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 569 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1997 | 2913 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2017 | 1399 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2175 | 0.020 |
Why?
|
| Focus Groups | 1 | 2014 | 1413 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1997 | 2208 | 0.020 |
Why?
|
| Reoperation | 2 | 1997 | 4303 | 0.020 |
Why?
|
| Body Constitution | 2 | 2003 | 273 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2142 | 0.020 |
Why?
|
| Lipodystrophy | 1 | 2009 | 145 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1376 | 0.020 |
Why?
|
| Quality Control | 1 | 2011 | 833 | 0.020 |
Why?
|
| Administrative Personnel | 1 | 2009 | 183 | 0.020 |
Why?
|
| World Health Organization | 2 | 2009 | 1321 | 0.020 |
Why?
|
| Surgical Wound Infection | 2 | 2013 | 1530 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 845 | 0.020 |
Why?
|
| Investments | 1 | 2009 | 147 | 0.020 |
Why?
|
| Rabbits | 2 | 2005 | 4750 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1528 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1244 | 0.020 |
Why?
|
| Sepsis | 1 | 2001 | 2585 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Carcinoma | 1 | 1998 | 2330 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 1267 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2008 | 221 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 1997 | 6819 | 0.020 |
Why?
|
| Confidence Intervals | 2 | 2006 | 2928 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2052 | 0.020 |
Why?
|
| Developed Countries | 1 | 2009 | 448 | 0.020 |
Why?
|
| Oxygen | 1 | 2017 | 4228 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4909 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2018 | 2493 | 0.020 |
Why?
|
| Psychometrics | 1 | 1995 | 3061 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 1996 | 2632 | 0.020 |
Why?
|
| Differential Threshold | 1 | 1985 | 80 | 0.020 |
Why?
|
| Xylose | 1 | 2005 | 28 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2008 | 15521 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3584 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2005 | 166 | 0.020 |
Why?
|
| Policy Making | 1 | 2009 | 541 | 0.020 |
Why?
|
| Metronidazole | 1 | 2006 | 232 | 0.020 |
Why?
|
| Sepharose | 1 | 2005 | 102 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2005 | 86 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 2006 | 217 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2006 | 527 | 0.010 |
Why?
|
| Biotinylation | 1 | 2005 | 184 | 0.010 |
Why?
|
| Urban Population | 1 | 2013 | 2036 | 0.010 |
Why?
|
| Surgical Stapling | 1 | 2005 | 98 | 0.010 |
Why?
|
| Monitoring, Immunologic | 1 | 2004 | 99 | 0.010 |
Why?
|
| HIV | 1 | 1991 | 1581 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 1876 | 0.010 |
Why?
|
| Postmenopause | 1 | 2013 | 2514 | 0.010 |
Why?
|
| Life Style | 1 | 2015 | 3907 | 0.010 |
Why?
|
| Goals | 1 | 2009 | 710 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2189 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1998 | 2421 | 0.010 |
Why?
|
| Peptidoglycan | 1 | 2005 | 246 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2005 | 344 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2006 | 732 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 7571 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 683 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 730 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2004 | 716 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 874 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 457 | 0.010 |
Why?
|
| Biological Assay | 1 | 2005 | 623 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 859 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 878 | 0.010 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2001 | 25 | 0.010 |
Why?
|
| Cytosol | 1 | 2005 | 883 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1997 | 12747 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2008 | 1812 | 0.010 |
Why?
|
| Epirubicin | 1 | 2001 | 81 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 575 | 0.010 |
Why?
|
| Aged | 7 | 2013 | 169292 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2005 | 577 | 0.010 |
Why?
|
| Viscosity | 1 | 2002 | 335 | 0.010 |
Why?
|
| Solutions | 1 | 2002 | 410 | 0.010 |
Why?
|
| Leukapheresis | 1 | 2001 | 134 | 0.010 |
Why?
|
| Biopolymers | 1 | 2002 | 183 | 0.010 |
Why?
|
| Ifosfamide | 1 | 2001 | 232 | 0.010 |
Why?
|
| Rheology | 1 | 2002 | 347 | 0.010 |
Why?
|
| Smoking | 1 | 2017 | 9055 | 0.010 |
Why?
|
| Colitis | 1 | 2009 | 1234 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 11733 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2001 | 353 | 0.010 |
Why?
|
| Kenya | 1 | 2003 | 756 | 0.010 |
Why?
|
| Body Temperature | 1 | 2003 | 780 | 0.010 |
Why?
|
| Elasticity | 1 | 2002 | 655 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 635 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 988 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2691 | 0.010 |
Why?
|
| Cell Separation | 1 | 2005 | 1721 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 1126 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2001 | 655 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2008 | 2380 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2981 | 0.010 |
Why?
|
| North America | 1 | 2002 | 1284 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 3778 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2009 | 2332 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5032 | 0.010 |
Why?
|
| Gastroscopes | 1 | 1997 | 19 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2003 | 1594 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 1998 | 235 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2001 | 2112 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1997 | 2196 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4111 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3412 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3661 | 0.010 |
Why?
|
| Gastroenterology | 1 | 2002 | 580 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2005 | 9187 | 0.010 |
Why?
|
| Cellulitis | 1 | 1997 | 208 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2871 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2001 | 1264 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5871 | 0.010 |
Why?
|
| Health Policy | 1 | 2007 | 2679 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1997 | 426 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1997 | 580 | 0.010 |
Why?
|
| Lung | 1 | 1993 | 9979 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3696 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2004 | 2688 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1998 | 1080 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 3843 | 0.010 |
Why?
|
| Vaccines | 1 | 2002 | 835 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 9297 | 0.010 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1993 | 139 | 0.010 |
Why?
|
| Lymphoma | 1 | 2001 | 1898 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1993 | 242 | 0.010 |
Why?
|
| Patient Participation | 1 | 2000 | 1445 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 7189 | 0.010 |
Why?
|
| Guilt | 1 | 1991 | 95 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 15545 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1997 | 3418 | 0.010 |
Why?
|
| Age Distribution | 1 | 1995 | 2871 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2002 | 3923 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 4246 | 0.000 |
Why?
|
| Bipolar Disorder | 1 | 1986 | 5092 | 0.000 |
Why?
|
| Rats | 1 | 2005 | 23705 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1993 | 1685 | 0.000 |
Why?
|
| Confidentiality | 1 | 1991 | 605 | 0.000 |
Why?
|
| Respiration | 1 | 1993 | 1657 | 0.000 |
Why?
|
| Colitis, Ulcerative | 1 | 1998 | 1920 | 0.000 |
Why?
|
| Crohn Disease | 1 | 1998 | 2278 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20588 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 11067 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1986 | 573 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1985 | 573 | 0.000 |
Why?
|
| Sensory Thresholds | 1 | 1985 | 377 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1985 | 958 | 0.000 |
Why?
|
| Computers | 1 | 1985 | 591 | 0.000 |
Why?
|
| Mice | 1 | 2005 | 81330 | 0.000 |
Why?
|